This study is looking for healthy adults to help us learn more about a medication called EDG-15400. We want to understand how safe EDG-15400 is, how well people tolerate it, and how much of it gets into the blood and urine after taking it. We'll also see if food affects how much EDG-15400 is absorbed and compare different forms of the medication (liquid versus tablet). Participants will receive either EDG-15400 or a placebo (an inactive substance) by mouth. The main goal is to check for any side effects. You can join if you are a healthy adult between 18 and 59 years old, with a BMI between 18.5 and 35, and weigh at least 55 kg.

Study design

This is an interventional study with 108 planned participants. Participants will receive either EDG-15400 or a placebo.

What's involved

Participants will receive single or multiple doses of EDG-15400 or placebo by mouth. The study involves monitoring for up to 25 days.

Compensation

Not stated in the trial record.

Follow-up

Participants will be monitored for safety for up to 25 days after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.